Cohance Lifesciences Shares In Focus: Here's Why The Former Cipla Top Boss Is A Strategic Fit

Vohra's track record at Cipla makes him a strategic fit for Cohance, which is itself navigating a similar transition, from volume manufacturing toward value-based partnerships with innovator and specialty pharma clients.

from NDTV Profit - Latest https://ift.tt/AioVgq9
Vohra's track record at Cipla makes him a strategic fit for Cohance, which is itself navigating a similar transition, from volume manufacturing toward value-based partnerships with innovator and specialty pharma clients.

Comments

Post a Comment

Popular posts from this blog

भारत-चीन की लड़ाई पहुंची बंदरगाहों पर! चीनी समान की हो रही है बारीकी से जांच

Image
India-China Standoff: पिछले कुछ दिनों से चेन्नई और मुंबई के पोर्ट पर चीन से आने वाले समानों की बारीकी से जांच हो रही है. लेकिन इसके पीछे कोई ठोस वजह नहीं बताई गई है. from Latest News चीन News18 हिंदी https://ift.tt/2Yz8FyY
Read more

RBI Vs Government: Finance Ministry To Shortly Issue A Statement

The government has invoked never-before-used powers under the RBI Act that allow it to issue directions to the central bank governor on matters of public interest. from NDTV Profit - Latest https://ift.tt/2P1gEl5 The government has invoked never-before-used powers under the RBI Act that allow it to issue directions to the central bank governor on matters of public interest.
Read more